Archer’s ‘lab‑on‑a‑chip’ advances toward human trials


David Allen
Reporter

Archer Materials has taken a step forward in its development of a tiny biomedical device that could soon be all that’s needed to analyse simple substances and eventually make complex diagnoses.

The ASX-listed quantum technology company on Friday said it is working to have a beta prototype of its Biosensor “within months”, putting it on track to commercialise the device.

Multiple versions of the prototype Biosensor will be created over …

Want to know how this story ends?

Become a subscriber for complete access to all stories on InnovationAus.com and our daily newsletter.

Already a member? Log in here

Do you know more? Contact James Riley via Email.

Related stories